Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settings

New Microbiologica

Volumn 36, Issue 2, 2013, Pages 121-132

  Parisi, Maria Rita ^a   Soldini, Laura ^b   Vidoni, Gianmarino ^c   Clemente, Felice ^a   Mabellini, Chiara ^a   Belloni, Teresa ^a   Nozza, Silvia ^a   Brignolo, Livia ^c   Negri, Silvia ^d   Rusconi, Stefano ^e   Schlusnus, Karin ^f   Dorigatti, Fernanda ^b   Lazzarin, Adriano ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Local Public Health Unit   (Italy)

^d ANLAIDS Lombardia Onlus   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f AIRON Communication srl   (Italy)

Author keywords

HIV positive submerged people; HIV prevention; HIV screening test; Late HIV diagnosis; Saliva oral fluid test

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; CHEMISTRY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; ITALY; MALE; MALE HOMOSEXUALITY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SALIVA; SEXUAL BEHAVIOR; STATISTICS;

ADULT; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HIV-2; HOMOSEXUALITY, MALE; HUMANS; ITALY; MALE; MASS SCREENING; MIDDLE AGED; SALIVA; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84878869481     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ANTINORI A., MARCOTULLIO S., AMMASSARI A., ANDREONI M., ANGARANO G., ET AL. (2011). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. New Microbiol. 35, 2, 113-159.
2. BORGHI V., GIRARDI E., BELLELLI S., ANGELETTI C., MUSSINI C., ET AL. (2008). Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J. Acquir. Immune Defic. Syndr. 49, 3, 282-286.
3. BRANSON B.M., HANDSFIELD H.H., LAMPE M.A., JANSSEN R.S., TAYLOR A.W., ET AL. (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm. Rep. 55, 1-17.
4. BRITISH HIV ASSOCIATION, BRITISH ASSOCIATION OF SEXUAL HEALTH AND HIV, BRITISH INFECTION SOCIETY. UK National Guidelines for HIV Testing 2008. http://www.bhiva.org/documents/Guidelines/Testing/GlinesHIVTest08.pdf.
5. CDC. (2011). Results of the expanded HIV testing initiative - 25 jurisdictions, United States, 2007-2010. MMWR. 60, 805-8010.
6. CENTER FOR DISEASE CONTROL AND PREVENTION (2008). False-positive oral fluid rapid HIV tests-New York City, 2005-2008. MMWR Morb. Mortal. Wkly. Rep. 57, 660-665.
7. CHOKO A.T., DESMOND N., WEBB E.L., CHAVULA K., NAPIERALA-MAVEDZENGE S., ET AL. (2011). The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 8, 1001-1002.
8. D'AMATO S., POMPA M.G. (2010). Aspects of the Italian legislation related to HIV testing. Ann. Ist. Super. Sanità. 46, 1, 51-56.
9. DE LA FUENTE L., ROSALES-STATKUS M.E., HOYOS J., PULIDO J., SANTOS S., ET AL. (2012). Are participants in a street-based HIV testing program able to perform their own rapid test and interpret the results? The Madrid Rapid HIV Testing Group. PLoS One. 7 (10), e46555.
10. DEBLOND J., MEULEMANS H., CALLENS S., LUCHTERS S., TEMMERMAN M., ET AL. (2011). HIV testing in Europe: mapping policies. Health Policy. 103, 2-3, 101-110.
11. ECDC. HIV testing: increasing uptake and effectiveness in the European Union. http://www.ecdc.europa.eu/en/publications/Publications/101129-GUI-HIV- testing.pdf.
12. FOOD AND DRUG ADMINISTRATION VACCINES, BLOOD & BIOLOGICS. July 3, 2012 Approval Letter, OraQuick In-Home HIV Test. http://www.fda.gov/ BiologicsBloodVaccines/BloodProducts/ApprovedProducts2012/
13. FRITH L., ET AL. (2007). HIV self-testing: a time to revise current policy. Lancet. 369, 243-245.
14. GAUTHIER R., LIVROZETB J.M., PREVOTEAU DU CLARYB F., TAULERAB O., BOUÉEB T., ET AL (2012). Feasibility and acceptability of rapid HIV test screening (DEPIVIH) by French family physicians. Med. Mal. Infect. 42, 11, 553-560.
15. GIRARDI E., ALOISI M.S., ARICI C., PEZZOTTI P., SERRAINO D., ET AL. FOR THE ICONA BEHAVIOURALEPIDEMIO LOGY STUDY GROUP. (2004). Delayed presentation and late testing for HIV: demographic and behavioural risk factors in a multicenter study in Italy. J. Acquired. Immune Deficiency Syndrome. 36, 4, 951-959.
16. KATZ D.A., DOMBROWSKI J.C., SWANSON F., BUSKIN S.E., GOLDEN M.R., ET AL. (2012). HIV interest interval among MSM in King County, Washington. Sex. Transm. Infect. 89, 1, 32-37.
17. LEE V.J., TAN S.C., EARNEST A., SEONG P.S., TAN H.H., ET AL. (2007). User acceptability and feasibility of self-testing with HIV rapid tests. J. Acquir. Immune Defic. Syndr. 45, 449-453.
18. MARKS G., CREPAZ N., JANSSEN R.S. (2006). Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 20, 1447-1450.
19. MERSON M.H., FELDMAN E.A., BAYER R., STRYKER J. (1997). Rapid self-testing for HIV infection. Lancet. 349 (9048), 352-353.
20. MORENO S., MOCROFT A., MONFORTE A. (2010). Medical and societal consequences of late presentation. Antivir. Ther. 15 Suppl 1, 9-15.
21. OFFICE OF NATIONAL AIDS POLICY. (2010). National HIV/AIDS strategy for the United States, Washington, DC. http://www.whitehouse.gov/administration/eop/ onap/nhas
22. OraQuick Rapid Antibody Test HIV-1/2, OraSure Technologies, Inc. Bethlehem, PA-USA. http://www.orasure.com/products-infectious/products- infectious-oraquick.asp
23. PARISI M.R., SOLDINI L., DI PERRI G., TIBERI S., LAZZARIN A., ET AL. (2009). Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs. New Microbiol. 32, 4, 391-396.
24. PAVIE J., RACHLINE A., LOZE B., NIEDBALSKI L., DELAUGERRE C., ET AL. (2010). Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS ONE 5, e11581.
25. SERVICE EVALUATION ECONOMIQUE ET SANTE PUBLIQUE. Dépistage de l'infection par le VIH en France. Stratégies et dispositif de depistage. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/2009- 10/argumentaire.
26. SPIELBERG F., BRANSON B.M., GOLDBAUM G.M., KURTH A., WOOD R.W. (2003). Designing an HIV counseling and testing program for bathhouses: the Seattle experience with strategies to improve acceptability. J. Homosex. 44, 3-4, 203-220.
27. SPIELBERG F., CAMPBELL S., RAMACHANDRA E. (2003). HIV Home Self-Testing: Can It Work? National HIV Prevention Conference, Atlanta. Abstract n. M1-A0101.
28. SPIELBERG F., LEVINE R.O., WEAVER M. (2004). Self-testing for HIV: a new option for HIV prevention? Lancet Infect. Dis. 4, 640-646.
29. THOMPSON M.A., ABERG J.A., CAHN P., MONTANER J.S., RIZZARDINI G., ET AL. (2010). Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 304, 321-333.
30. U.S. Food and Drug Administration. Vaccines, Blood & Biologics. July 3, 2012 Approval Letter, OraQuick In-Home HIV Test. http://www.fda.gov/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/
31. VV.AA. (2000). Home HIV testing: why not in Canada? Canadian Medical Association or its licensors. CMAJ. 162, 1545-1547.
32. WALENSKY R.P., PALTIEL A.D. (2006). Rapid HIV testing at home: does it solve a problem or create one? Ann. Intern. Med. 145, 459-462.
33. WHO Regional Office for Europe. Scaling up HIV testing and counselling in the WHO European Region as an essential component of efforts to achieve universal access to HIV prevention, treatment, care and support. http://www.euro.who.int/data/assets/pdf-file/0007/85489/E93715.pdf